Abstract
Coagulopathy and elevated D-dimer levels were recognized as prognostic factors early in Wuhan, China as accompanying more severe COVID-19 patient cases. We sought to determine the accuracy of normal vs elevated D-dimer blood levels at presentation, day 1, and on day 3 for predicting 28-day survival in a large cohort of consecutive PCR-proven COVID-19 patients, to help with patient triage, reassurance, and follow-up management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
